Clinical Trial Update: A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To [Phase 2]

View source ↗

Summary

Pfizer conducted a Phase 2 study to measure drug levels in nasal tissue and blood after a single 2 g dose or 500 mg tablets in sinusitis; the trial has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sinusitis

Drugs mentioned

• Pfizer investigational drug

Snippet

Sponsor: Pfizer | Conditions: Sinusitis | Phase 2 | Status: COMPLETED